Statement of Task
The study will review the current state of tuberculosis mortality, morbidity, and prevention/control efforts in the United States, with special emphasis on regional and other variations; assess special challenges and solutions for the high proportion of U.S. cases of TB in foreign-born persons; and review the current state of research and development in the United States on new diagnostics and therapeutics for TB prevention, control and elimination; review the extent of multi-drug resistant tuberculosis and analyze factors that contribute to its development; and examine the role of the United States in international efforts at tuberculosis control. The committee will develop conclusions and recommendations regarding: a framework to guide a national campaign to eliminate TB in the United States; region-specific action steps required to work towards that goal; research needs and priorities for national TB elimination; information for health care providers and the public regarding the importance of vigilant and continued attention to TB control; health plan (fee-for-service and managed care) responsibilities for TB prevention and control; federal, state, and local public health policy maker's responsibilities and options regarding infrastructure needs; and strategies for U.S. contributions to worldwide TB prevention and control, leading to worldwide TB elimination.
The study will be carried out by a committee of 15 members with expertise in epidemiology, health policy, public health, clinical medicine, microbiology/basic sciences, international health, and social sciences. The
slate of nominees was drawn up so that the committee would be composed, in roughly equal numbers, of nominees with extensive experience and expertise in tuberculosis issues, those with limited tuberculosis experience, and those with no significant tuberculosis experience. The completed report will be delivered to the sponsor, the Centers for Disease Control and Prevention, no later than July 31, 2000.